Congenital juvenile chronic myelogenous leukemia: Therapeutic trial with interferon alpha-2
- 1 January 1993
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 21 (1), 73-76
- https://doi.org/10.1002/mpo.2950210115
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.JCI Insight, 1988
- The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia.Journal of Clinical Oncology, 1987
- Juvenile chronic myelogenous leukemia: characterization of the disease using cell culturesBlood, 1986
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986
- Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factorsCancer, 1984
- Characterization of hemopoietic precursor cells in juvenile-type chronic myelocytic leukemiaLeukemia Research, 1982
- Juvenile Chronic Granulocytic LeukemiaAmerican Journal of Diseases of Children, 1980
- Treatment of juvenile chronic myeloid leukemia with sequential subcutaneous cytarabine and oral mercaptopurineBlood, 1977
- The Esterase Activity in Megaloblasts, Leukaemic and Normal Haemopoietic CellsBritish Journal of Haematology, 1968
- Granulocytic Leukaemia in ChildhoodBritish Journal of Haematology, 1964